Skip to main content
. Author manuscript; available in PMC: 2013 Aug 12.
Published in final edited form as: Ther Drug Monit. 2008 Oct;30(5):620–627. doi: 10.1097/FTD.0b013e318185813d

Table 4.

Stability of lenalidomide and flavopirodol in human plasma and in mobile phase post-processing.

Lenalidomide Flavopirodol

Accuracy (mean ±S.D., %) Accuracy (mean ±S.D. %)

3nM 50nM 800nM 3nM 50nM 800nM
Freeze-thaw stability 103 ± 12 93 ± 5 89 ± 8 96 ± 19 103 ± 20 90 ± 11
Post-preparative stability 91.7 ± 4.7 95.0 ± 5.2 95.8 ± 9.0 91.9 ± 6.3 96.0 ± 3.9 92.0 ± 5.0